Rentokil Initial plcLSE: RTO

Rentokil Initial: Transaction in Own Shares

· Issued by Rentokil Initial plc via RNS

Filed with LSE · · 55 pages · English

Summary by 6ix AI

This filing is a transaction report detailing the purchase of shares by Rentokil Initial plc. The report includes aggregate information about the purchases, including average prices and volumes.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Rentokil Initial PLC
10 November 2026

10 November 2026

Rentokil Initial plc (the "Company")

Purchase of own shares

The Company announces that, from 02 November 2026 up to and including 06 November 2026, it has purchased the following number of its ordinary shares through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 7 May 2026 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 27 October 2026 as announced on 22 October 2026.

Date of Purchase

Number of ordinary shares purchased

Volume weighted price paid per share

Lowest price paid per share

Highest price paid per share

2026-11-02

464,386

£3.5320

£3.4780

£3.5730

2026-11-03

454,598

£3.5388

£3.5200

£3.5640

2026-11-04

458,113

£3.5602

£3.4950

£3.6030

2026-11-05

450,481

£3.6051

£3.5770

£3.6340

2026-11-06

449,769

£3.5187

£3.4780

£3.5550

The Company intends to cancel the purchased shares.

Following the cancellation of the repurchased shares, the Company has 2,521,907,313 ordinary shares in issue. The Company does not hold any shares in treasury. This information may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Since 27 October 2026, the Company has purchased 4,132,572 ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at:

http://www.rns-pdf.londonstockexchange.com/rns/4355C_1-2026-11-9.pdf

Enquiries:

For further information, please contact:

Investors / Analysts:

Heather Wood, Rentokil Initial plc, +44 7808 098793

Jamie Lewis, Rentokil Initial plc, +44 7341 071944

Media:

Malcolm Padley, Rentokil Initial plc, +44 7788 978 199

About Rentokil Initial plc

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Rentokil Initial plc on 6ix

Earlier from Rentokil Initial

All Rentokil Initial news releases